Is AHC-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AHC-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AHC-R (THB15.8) is trading above our estimate of fair value (THB9.15)
Significantly Below Fair Value: AHC-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AHC-R?
Key metric: As AHC-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for AHC-R. This is calculated by dividing AHC-R's market cap by their current
earnings.
What is AHC-R's PE Ratio?
PE Ratio
14x
Earnings
฿168.93m
Market Cap
฿2.37b
AHC-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: AHC-R is good value based on its Price-To-Earnings Ratio (14x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is AHC-R's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
AHC-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
14x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AHC-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.